Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Finnigan and Proteome Systems Enter into Distribution Agreement

NEW YORK, Aug. 21 – Thermo Finnigan and Proteome Systems have entered into an agreement to integrate and distribute selected items of each other’s products, the companies announced Tuesday.

Sydney, Australia-based Proteome Systems will integrate several of Thermo Finnigan’s products into its ProteomIQ technology, including Thermo Finnigan’s Surveyor liquid chromatography system, LCQ Deca XP ion-trap mass spectrometer, the TurboSEQUEST protein identification software, and chromatography columns and packings from Thermo Hypersil-Keystone.

Thermo Finnigan, based in San Jose, Calif., will gain access to Proteome Systems' sample preparation technology for its electrospray mass spectrometer, including technology for introducing protein samples from gels into mass spectrometers.

Financial details of the agreement were not disclosed.

"We see this partnership as a critical step in Thermo Finnigan's evolution from a manufacturer of proteomics hardware and software into a provider of complete solutions for proteomics researchers," Ian Jardine, president of Thermo Finnigan, said in a statement.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.